[HTML] springer.comFull View

[HTML][HTML] Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL

M Kannagi, A Hasegawa, Y Nagano, S Kimpara… - Retrovirology, 2019 - Springer
Human T-cell leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL),
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), and other …
被引用次数：40 相关文章

Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL

M Kannagi, A Hasegawa, Y Nagano, S Kimpara… - Retrovirology, 2019 - go.gale.com
Human T-cell leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL),
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), and other …

[引用][C] Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL

M Kannagi, A Hasegawa, Y Nagano, S Kimpara… - Retrovirology, 2019 - cir.nii.ac.jp
Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy
against ATL | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …

Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL

M Kannagi, A Hasegawa, Y Nagano… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Human T-cell leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL),
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), and other …

[引用][C] Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL

M Kannagi, A Hasegawa, Y Nagano, S Kimpara… - Retrovirology …, 2019 - jglobal.jst.go.jp
Int J Cancer; Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with
human T-lymphotropic virus type I; EL Murphy, B Hanchard, JP Figueroa, WN Gibbs, WS …

Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL

M Kannagi, A Hasegawa, Y Nagano, S Kimpara… - …, 2019 - search.proquest.com
Background Human T-cell leukemia virus type-1 (HTLV-1) causes two distinct diseases,
adult T-cell leukemia/lymphoma (ATL) in approximately 4% and HTLV-1-associated …

Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL

M Kannagi, A Hasegawa, Y Nagano, S Kimpara… - Retrovirology, 2019 - infona.pl
Human T-cell leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL),
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), and other …
[HTML] nih.gov

[HTML][HTML] Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL

M Kannagi, A Hasegawa, Y Nagano, S Kimpara… - …, 2019 - ncbi.nlm.nih.gov
Background Human T-cell leukemia virus type-1 (HTLV-1) causes two distinct diseases,
adult T-cell leukemia/lymphoma (ATL) in approximately 4% and HTLV-1-associated …

Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL

M Kannagi, A Hasegawa, Y Nagano, S Kimpara… - …, 2019 - sciprofiles.com
Human T-cell leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL),
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), and other …

Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.

M Kannagi, A Hasegawa, Y Nagano, S Kimpara… - …, 2019 - europepmc.org
Background Human T-cell leukemia virus type-1 (HTLV-1) causes two distinct diseases,
adult T-cell leukemia/lymphoma (ATL) in approximately 4% and HTLV-1-associated …